A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLELGROUP, ADULT LABORATORY CLASSROOM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PRC-063 COMPARED TO PLACEBO IN ADULTS WITH ADHD

Administered By

Awarded By

Contributors

Start/End

  • December 12, 2018 - April 30, 2020